| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | XMD17-109 |
|---|
| Description | XMD17-109 is a novel, specific ERK-5 inhibitor, which inhibits the ERK5-mediated AP1 transcriptional activity at 30 μM, and has an EC50 of 4.2 μM. MW: 638.8. Purity >98% |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | XMD17-109; XMD17 109; XMD17109; 11-cyclopentyl-2-[2-ethoxy-4-[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]anilino]-5-methylpyrimido[4,5-b][1,4]benzodiazepin-6-one |
|---|
| Gene, Accession, CAS # | CAS: 1435488-37-1 |
|---|
| Catalog # | B1685-5 |
|---|
| Price | |
|---|
| Order / More Info | XMD17-109 from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|